ALDH7A1 and chronic obstructive pulmonary disease: The discovery of phosphodiesterase isoenzymes (PDEs) along with increased understanding of their different function based on the tissue/cell specificity was a driving force for the development of PDE selective inhibitors for the treatment of various diseases including COPD.